Epigenetics of Aging and Longevity

Dr. Alexey Moskalev earned his PhD from Moscow State University, Moscow, Russia in 2001. Since that time, Dr. Moskalev’s research has focused on the genetics of longevity and aging, with emphasis on epigenetic regulation of aging, longevity, and stress resistance in animal models. He was a key contributor towards creating a database of biomarkers of aging in the Digital Ageing Atlas (DAA), and his lab has been supported by grants from the Russian Basic Research Foundation, the Presidium of the Russian Academy of Sciences, and the President of the Russian Federation through a program that funds leading young scientists. Currently, Dr. Moskalev is Vice-President of the Syktyvkar Branch of Russian Gerontology Society; President of the Komi branch of the Vavilov Society of Geneticists and Breeders; and a member of the editorial boards of Aging, Biogerontology, Frontiers in Genetics of Aging, Aging and Disease, Genes & Cells, and the SM Journal of Food and Nutritional Disorders. Additionally, he is Co-chair of the International Symposiums “Genetics of Aging and Longevity” and “Biomedical Innovation For Healthy Longevity”. Dr. Moskalev has published more than eighty scientific papers in peer reviewed journals on topics related to the genetics of aging and longevity, as well as DNR repair and defense genes in animal models. Dr. Vaiserman is head of the Laboratory of Epigenetics at the Institute of Gerontology, where his research has focused on long-term health consequences of adverse conditions in early life, genetic and epigenetic mechanisms of age-associated diseases, telomere length in patients with age-related chronic diseases, and molecular mechanisms mediating lifespan in Drosophila. He earned his PhD from the Institute of Gerontology, Kiev, Ukraine in 2004. During the last 7 years, Dr. Vaiserman was Project Leader for several Ukrainian government sponsored research projects. Dr. Vaiserman is also a member of the editorial boards of the journals Biogerontology, Frontiers in Genetics of Aging, and Gerontology & Geriatric Research. To-date, he has published four book chapters, as well as 65 papers in peer reviewed journals.

• Section I: Epigenetic Mechanisms in Aging1. Aging epigenetics: changes and challenges2. Defective DNA methylation/demethylation processes define aging-dependent methylation patterns3. S-adenosylmethionine Metabolism and Aging4. The Epigenetic Clock and Ageing5. The Epigenetic Regulation of Telomere Maintenance in Aging6. Living Long and Ageing Well: Are Lifestyle factors the Epigenetic link in the Longevity Phenotype?7. Epigenetic Biomarkers for Biological Age8. The Role of Non-Coding RNAs in Genome Stability and Aging9. Intra-tissue DNA methylation heterogeneity in agingSection II. Early-life Epigenetic Programming of Aging Trajectories10. Early Life Nutrition, Epigenetics and Altered Energy Balance Later in Life11. Early Nutrition, Epigenetics and Human Health12. Biological Embedding of Psychosocial Stress over the Life Course13. Epigenetics of longevity in social insectsSection III. Epigenetics of Aging-Associated Diseases14. Drosophila melanogaster as a Model for Studying the Epigenetic Basis of Aging15. Histone modification changes during aging: Cause or Consequence? - What we have learned about epigenetic regulation of aging from model organisms16. Epigenetics of brain/cognitive aging17. The role of epigenetic modifications in cardiometabolic diseases18. Epigenetic mechanisms in osteoporosis19. Epigenetics of Skeletal Muscle AgingSection IV. Epigenome-targeted Therapies in Gerocscience20. Healthy Aging and Epigenetic Drugs for Diabetes and Obesity: A Novel Perspective21. Epigenetic Drugs for Cancer and Precision Medicine22. Epigenetic Drug Discovery for Alzheimer’s DiseaseSection V. Conclusions and Perspectives23. Epigenetics of aging and longevity: challenges and future directions